Table 2.
Enhancement pattern of metastases and haemangiomas on gadoxetic acid vs. gadoxetic acid/gadofosveset-enhanced liver MRI
| Enhancement pattern | Reader 1
|
Reader 2
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gadoxetic acid alone
|
Gadoxetic acid/gadofosveset
|
Gadoxetic acid alone
|
Gadoxetic acid/gadofosveset
|
|||||||||||||
| Metastasis | Haemangioma | Metastasis | Haemangioma | Metastasis | Haemangioma | Metastasis | Haemangioma | |||||||||
| None/negligible | 92 | 88 % | 15 | 94 % | 78 | 75 % | 0 | 0 % | 72 | 70 % | 15 | 94 % | 61 | 59 % | 0 | 0 % |
| Central | 2 | 2 % | 0 | 0 % | 6 | 6 % | 0 | 0 % | 15 | 14 % | 0 | 0 % | 9 | 9 % | 0 | 0 % |
| Ring | 8 | 8 % | 0 | 0 % | 12 | 11 % | 0 | 0 % | 8 | 8 % | 0 | 0 % | 13 | 13 % | 0 | 0 % |
| Heterogeneous | 2 | 2 % | 1 | 6 % | 8 | 8 % | 0 | 0 % | 8 | 8 % | 1 | 6 % | 20 | 19 % | 0 | 0 % |
| Peripheral nodular | 0 | 0 % | 0 | 0 % | 0 | 0 % | 5 | 31 % | 0 | 0 % | 0 | 0 % | 0 | 0 % | 2 | 13 % |
| Homogenous | 0 | 0 % | 0 | 0 % | 0 | 0 % | 11 | 69 % | 0 | 0 % | 0 | 0 % | 0 | 0 % | 14 | 87 % |
| Total | 104 | 100 % | 16 | 100 % | 104 | 100 % | 16 | 100 % | 103 | 100 % | 16 | 100 % | 103 | 100 % | 16 | 100 % |
Total numbers correspond to the number of lesions that each reader detected on gadoxetic acid alone enhanced images. Percentages are rounded